AL
SRNE

Airain Ltd’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Airain Ltd’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21,456
Closed -$187K – 1135
2015
Q4 		$187K Buy
+21,456
New +$181K 0.01% 734
2015
Q2 		– Sell
-11,972
Closed -$138K – 1146
2015
Q1 		$138K Buy
+11,972
New +$139K 0.01% 744

Other funds holding SRNE

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Airain Ltd's SRNE Position: Q1 2016 in Review

Airain Ltd sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2016, closing a stake of 21,456 shares — an estimated $187K sold.

Airain Ltd first reported a position in SRNE in Q1 2015 and held it in 2 quarters. The position peaked at $187K in Q4 2015. 68 funds tracked by Wall St. Rank hold SRNE as of Q1 2016.

  • Airain Ltd reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 21,456 Sorrento Therapeutics, Inc. shares in Q1 2016, an estimated $187K.
  • Airain Ltd first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 2 quarters.
  • Airain Ltd's Sorrento Therapeutics, Inc. position peaked at $187K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.